Usage of AOD-9604 outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C
The classification of a medicine is based on the level of health professional input needed to diagnose and manage the conditions for which the product is used
Fat loss continues at an accelerated rate
Kintscher, U., Foryst-Ludwig, A., Haemmerle, G
In both obese and nonobese subjects, fasting and weight reduction cause a significant enhancement of sensitivity to the antilipolytic effects of insulin (7, 28, 71)
NAD+ Injections: Improve energy, cognitive function, and recovery from physical exertion